The Womb Cancer Awareness Measure (WCAM): development of an instrument to assess public awareness of endometrial cancerOlivia Jones, Hannah Young, Helen Clarke, Emma J Crosbie, Vanitha N Sivalingam
6 December 2023
Centralizing surgery for ovarian cancer in a ‘non-centralizing’ country (Belgium): the UNGO (UCLouvain Network of Gynaecological Oncology) experienceMathieu Luyckx, Mathieu Jouret, Kismendsida Sawadogo, Marc Waterkeyn, Frédéric Grandjean, Jean-Paul Van Gossum, Nathanael Dubois, Vincent Malvaux, Lucie Verreth, Pascale Grandjean, Annika Malin Bruger, Pascale Jadoul, Charlotte Maillard, Amandine Gerday, Jean-François BaurainSee the full list of authors
16 October 2023
Real-world data on niraparib maintenance treatment in patients with non-gBRCA mutated platinum-sensitive recurrent ovarian cancerBente Vilming, Jørgen Fallås Dahl, Anne Gry Bentzen, Vibeke Anett Ingebrigtsen, Elisabeth Berge Nilsen, Ingvild Vistad, Anne Dørum, Olesya Solheim, Line Bjørge, Manuela Zucknick, Guro Aune, Kristina Lindemann
24 November 2023
Developing a hyperthermic intraperitoneal chemotherapy (HIPEC) gynecologic oncology program: a Canadian experienceJoannie Neveu, Elizabeth Tremblay, Frederic Mercier, Sébastien Garneau, Beatrice Cormier
27 November 2023
Time to extend the indication for sentinel node biopsy in vulvar cancer? Results from a prospective nationwide Swedish studyDiana Zach, Katja Stenström Bohlin, Paivi Kannisto, Louise Moberg, Preben Kjölhede
2 November 2023
The promise of combining CDK4/6 inhibition with hormonal therapy in the first-line treatment setting for metastatic or recurrent endometrial adenocarcinomaIsabelle Ray-Coquard, Bradley J Monk, Domenica Lorusso, Haider Mahdi, Vivek Upadhyay, Regina Graul, Amreen Husain, Mansoor Raza Mirza, Brian Slomovitz
31 October 2023
The OVANORDEST project: making an impact on ovarian cancer in MoroccoKhalid El Bairi, Ouissam Al Jarroudi, Said Afqir
11 September 2023
How to break bad news and how to learn this skill: results from an international North-Eastern German Society for Gynecological Oncology (NOGGO) survey among physicians and medical students with 1089 participantsEmilie M Herzog, Adak Pirmorady Sehouli, Jolijn Boer, Klaus Pietzner, Edgar Petru, Viola Heinzelmann, Eva Roser, Desislava Dimitrova, Gülten Oskay-Özcelik, Oumar Camara, Jalid Sehouli
4 December 2023
Efficacy and safety of zimberelimab (GLS-010) monotherapy in patients with recurrent or metastatic cervical cancer: a multicenter, single-arm, phase II studyLingfang Xia, Jing Wang, Chunyan Wang, Qingming Zhang, Jianqing Zhu, Qunxian Rao, Huijun Cheng, Zheng Liu, Yongmei Yin, Xiaohong Ai, Kurban Gulina, Hong Zheng, Xiaoyong Luo, Baoping Chang, Li LiSee the full list of authors
24 October 2023
Evolving treatment paradigms in metastatic or recurrent low-grade endometrial cancer: When is hormonal-based therapy the preferred option?Haider Mahdi, Isabelle Ray-Coquard, Domenica Lorusso, Mansoor Raza Mirza, Bradley J Monk, Brian Slomovitz
27 August 2023